nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Analysis of feasibility and toxicity of concurrent chemoradiotherapy with S-1 for locally advanced squamous cell carcinoma of the head and neck in elderly cases and/or cases with comorbidity
|
Tsukuda, Mamoru |
|
2009 |
64 |
5 |
p. 945-952 |
artikel |
2 |
A phase II study of capecitabine in the treatment of ovarian cancer resistant or refractory to platinum therapy: a multicentre Italian trial in ovarian cancer (MITO-6) trial
|
Pisano, Carmela |
|
2009 |
64 |
5 |
p. 1021-1027 |
artikel |
3 |
A phase I study of gemcitabine given via intrahepatic pump for primary or metastatic hepatic malignancies
|
Tse, Archie N. |
|
2009 |
64 |
5 |
p. 935-944 |
artikel |
4 |
A sphingosine kinase inhibitor induces cell death in temozolomide resistant glioblastoma cells
|
Bektas, Meryem |
|
2009 |
64 |
5 |
p. 1053-1058 |
artikel |
5 |
Bleomycin, vinorelbine and trofosfamide in relapsed stage IV cutaneous malignant melanoma patients
|
Atzpodien, Jens |
|
2009 |
64 |
5 |
p. 901-905 |
artikel |
6 |
Bone marrow CFU-GM and human tumor xenograft efficacy of three tubulin binding agents
|
Kurtzberg, Leslie S. |
|
2009 |
64 |
5 |
p. 1029-1038 |
artikel |
7 |
Cediranib (recentin, AZD2171) reverses ABCB1- and ABCC1-mediated multidrug resistance by inhibition of their transport function
|
Tao, Li-yang |
|
2009 |
64 |
5 |
p. 961-969 |
artikel |
8 |
Chemoprotection and enhancement of cancer chemotherapeutic efficacy of cyclophosphamide in mice bearing Ehrlich ascites carcinoma by diphenylmethyl selenocyanate
|
Chakraborty, Pramita |
|
2009 |
64 |
5 |
p. 971-980 |
artikel |
9 |
Delivery of high levels of anti-proliferative nucleoside triphosphates to CYP3A-expressing cells as a potential treatment for hepatocellular carcinoma
|
MacKenna, Deidre A. |
|
2009 |
64 |
5 |
p. 981-991 |
artikel |
10 |
Distinct mechanistic activity profile of pralatrexate in comparison to other antifolates in in vitro and in vivo models of human cancers
|
Izbicka, E. |
|
2009 |
64 |
5 |
p. 993-999 |
artikel |
11 |
Dose-finding study of docetaxel, oxaliplatin, and S-1 for patients with advanced gastric cancer
|
Zang, Dae Young |
|
2009 |
64 |
5 |
p. 877-883 |
artikel |
12 |
Downregulation of matrix metalloprotease-9 and urokinase plasminogen activator by TX-1877 results in decreased tumor growth and metastasis on xenograft model of rectal cancer
|
Miyake, Kotaro |
|
2009 |
64 |
5 |
p. 885-892 |
artikel |
13 |
Fotemustine and recurrent glioblastoma: possible new opportunities for an old drug
|
Addeo, Raffaele |
|
2009 |
64 |
5 |
p. 863-866 |
artikel |
14 |
Inhibition of drug metabolizing cytochrome P450s by the aromatase inhibitor drug letrozole and its major oxidative metabolite 4,4′-methanol-bisbenzonitrile in vitro
|
Jeong, Seongwook |
|
2009 |
64 |
5 |
p. 867-875 |
artikel |
15 |
In vivo activity of gemcitabine-loaded PEGylated small unilamellar liposomes against pancreatic cancer
|
Cosco, Donato |
|
2009 |
64 |
5 |
p. 1009-1020 |
artikel |
16 |
Irinotecan and oxaliplatin combination as the first-line treatment for patients with advanced non-small cell lung cancer
|
Chang, Myung Hee |
|
2009 |
64 |
5 |
p. 917-924 |
artikel |
17 |
Long-term results of gemcitabine plus oxaliplatin with and without rituximab as salvage treatment for transplant-ineligible patients with refractory/relapsing B-cell lymphoma
|
Corazzelli, Gaetano |
|
2009 |
64 |
5 |
p. 907-916 |
artikel |
18 |
Oxaliplatin, irinotecan, and fluorouracil/folinic acid in advanced gastric cancer: a multicenter phase II trial of the Southern Italy Cooperative Oncology Group
|
Comella, Pasquale |
|
2009 |
64 |
5 |
p. 893-899 |
artikel |
19 |
Perturbation of DNA repair pathways by proteasome inhibitors corresponds to enhanced chemosensitivity of cells to DNA damage-inducing agents
|
Takeshita, Takashi |
|
2009 |
64 |
5 |
p. 1039-1046 |
artikel |
20 |
Polymorphisms in p53, GSTP1 and XRCC1 predict relapse and survival of gastric cancer patients treated with oxaliplatin-based adjuvant chemotherapy
|
Huang, Zhao-Hui |
|
2009 |
64 |
5 |
p. 1001-1007 |
artikel |
21 |
Prostaglandin synthase 2/cyclooxygenase 2 (PTGS2/COX2) 8473T>C polymorphism associated with prognosis for patients with colorectal cancer treated with capecitabine and oxaliplatin
|
Kim, Jong Gwang |
|
2009 |
64 |
5 |
p. 953-960 |
artikel |
22 |
The acute effects of CMF-based chemotherapy on maxillary periodontal microcirculation
|
Milstein, Dan M. J. |
|
2009 |
64 |
5 |
p. 1047-1052 |
artikel |
23 |
The relative activity of cisplatin, oxaliplatin and satraplatin in testicular germ cell tumour sensitive and resistant cell lines
|
Perry, Jackie |
|
2009 |
64 |
5 |
p. 925-933 |
artikel |